Magenta therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Magenta therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 22.644 million compared to usd 16.702 million a year ago. net loss was usd 20.990 million compared to usd 16.015 million a year ago. basic loss per share was usd 0.54 compared to usd 0.49 a year ago. for the nine months, operating loss was usd 58.332 million compared to usd 42.033 million a year ago. net loss was usd 53.532 million compared to usd 40.836 million a year ago. basic loss per share was usd 1.47 compared to usd 3.05 a year ago.
DNTH Ratings Summary
DNTH Quant Ranking